56 Biggest Movers From Yesterday

從昨天開始的56個最大的轉會

Benzinga Real-time News · 2021/11/24 05:00

Gainers

Aptevo Therapeutics Inc. (NASDAQ:APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Pasithea Therapeutics Corp. (NASDAQ:KTTA) shares surged 153.4% to close at $5.60 on Tuesday after the company announced its subsidiary Pasithea Clinics has been approved to provide esketamine nasal spray for the treatment of resistant depression in adults.
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) surged 104.8% to close at $2.56 after a Zack's Small Cap research note showed a $9 price target on the stock.
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) jumped 81.6% to settle at $7.30. HC Wainwright & Co, on Monday, initiated coverage on Vallon Pharmaceuticals with a Buy rating and announced a price target of $12.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) gained 75.9% to settle at $2.34. The company filed proxy statement for annual meeting after the market close on Monday.
iSpecimen Inc. (NASDAQ:ISPC) gained 48.5% to close at $13.19. iSpecimen shares jumped over 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
MediciNova, Inc. (NASDAQ:MNOV) surged 44% to settle at $4.42. Zacks Small-Cap Research set $27 valuation on MediciNova.
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) gained 43% to close at $5.74 after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
Esperion Therapeutics, Inc. (NASDAQ:ESPR) surged 40.7% to settle at $10.02
Sunlands Technology Group (NYSE:STG) rose 23.2% to close at $4.51 after reporting unaudited Q3 results.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) rose 22.1% to close at $7.79. Gracell Biotech said members of its senior mgmt. team, including, Chair, CEO, CFO, Chief Medical Officer intend to use personal funds to buy up to $2 million in company’s ADSs in open market over next 3 months.
Dycom Industries, Inc. (NYSE:DY) climbed 19.7% to close at $99.91 following upbeat Q3 results.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) gained 15.1% to settle at $86.50 after the company reported Q4 earnings results.
BM Technologies, Inc. (NYSE:BMTX) jumped 14.9% to close at $13.82. Chardan Capital initiated coverage on BM Technologies with a Buy rating and announced a price target of $21.
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) rose 14.7% to close at $2.88. Unicycive Therapeutics recently posted a Q3 loss of $0.37 per share.
Reliance Global Group, Inc. (NASDAQ:RELI) gained 14.7% to settle at $2.42.
Armata Pharmaceuticals Inc. (NYSE:ARMP) jumped 14.3% to settle at $5.53. The FDA recently cleared Armata Pharmaceuticals’ Investigational New Drug (IND) for Phase 1b/2a study of AP-SA02 in Staphylococcus aureus bacteremia.
QIWI plc (NASDAQ:QIWI) rose 12.7% to settle at $8.70 after the company reported better-than-expected Q3 sales results.
Movado Group, Inc. (NYSE:MOV) gained 11.7% to close at $44.58 following Q3 results.
Dollar Tree, Inc. (NASDAQ:DLTR) surged 9.2% to settle at $144.71 after the company reported better-than-expected Q3 sales results.
Kosmos Energy Ltd. (NYSE:KOS) gained 9.1% to close at $3.71.
Burlington Stores, Inc. (NYSE:BURL) surged 8.6% to close at $285.55 after the company reported better-than-expected Q3 results.
XPeng Inc. (NYSE:XPEV) jumped 8.3% to close at $51.30. XPeng reported third-quarter revenues that exceeded expectations but the loss per share trailed expectations. The company's gross margins expanded both sequentially and year-over-year.
XL Fleet Corp. (NYSE:XL) gained 6.7% to close at $4.95 after the company announced it was awarded a pilot project with the Department of Defense to prototype fuel-saving technology for tactical vehicles.
Western Digital Corporation (NASDAQ:WDC) gained 6.3% to close at $60.53. Mizuho analyst Vijay Rakesh upgraded Western Digital to Buy from Neutral with a price target of $75, up from $55, implying a 31.7% upside.
Soligenix, Inc. (NASDAQ:SNGX) rose 5.8% to settle at $0.8790. Soligenix recently posted a Q3 loss of $0.09 per share.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares rose 4.9% to close at $0.4882. The FDA has signed off Tonix Pharmaceuticals’ Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.

Check out these big penny stock gainers and losers

Losers

Society Pass Incorporated (NASDAQ:SOPA) dipped 71.3% to close at $11.18 on Tuesday. The company, earlier during the month, priced its IPO at $9 per share.
Longeveron Inc. (NASDAQ:LGVN) shares dropped 38.9% to close at $17.22 on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
Enjoy Technology, Inc. (NASDAQ:ENJY) fell 33.5% to close at $4.30. Enjoy Technology recently posted Q3 loss of $0.83 per share.
Greenland Technologies Holding Corporation (NASDAQ:GTEC) fell 28.1% to close at $8.41. Greenland Technologies will present at the upcoming Sequire Cleantech & Electric Vehicle Investor Conference to be held virtually on December 6, 2021.
Genius Sports Limited (NYSE:GENI) fell 25.3% to close at $10.19 after the company reported better-than-expected Q3 sales results and raised FY21 sales guidance above estimates.
Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 22.2% to settle at $2.25.
Entrada Therapeutics, Inc. (NASDAQ:TRDA) dipped 20.6% to close at $24.13. Goldman Sachs initiated coverage on Entrada Therapeutics with a Neutral rating and announced a price target of $29.
Vinco Ventures, Inc. (NASDAQ:BBIG) declined 20% to close at $3.13. Vinco Ventures reported a third-quarter FY21 sales decline of 11.5% year-on-year, to $2.23 million.
Local Bounti Corp. (NYSE:LOCL) dipped 19.1% to settle at $8.01.
Aurora Innovation, Inc. (NASDAQ:AUR) fell 18.7% to close at $12.15.
Sarcos Technology and Robotics Corporation (NASDAQ:STRC) dropped 18% to settle at $6.58. Credit Suisse initiated coverage on Sarcos Technology with a Neutral rating and announced a price target of $9.
Benson Hill, Inc. (NYSE:BHIL) dipped 17.6% to settle at $6.10. Goldman Sachs initiated coverage on Benson Hill with a Neutral rating and announced a price target of $9.
Science 37 Holdings, Inc. (NASDAQ:SNCE) fell 17.1% to close at $9.43.
PainReform Ltd. (NASDAQ:PRFX) fell 17% to close at $1.91. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.
Femasys Inc. (NASDAQ:FEMY) dipped 16.8% to settle at $4.06.
Design Therapeutics, Inc. (NASDAQ:DSGN) fell 16.3% to close at $17.00.
Momentus Inc. (NASDAQ:MNTS) dropped 15.5% to settle at $6.88.
Tyra Biosciences, Inc. (NASDAQ:TYRA) declined 15.5% to settle at $19.34.
Zoom Video Communications, Inc. (NASDAQ:ZM) fell 14.7% to close at $206.64. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. B of A Securities downgraded Zoom from Buy to Neutral and lowered the price target from $385 to $270.
GameStop Corp. (NYSE:GME) dropped 13.6% to settle at $213.90 amid overall weakness as a rise in yields weighs on stocks.
Abercrombie & Fitch Co. (NYSE:ANF) fell 12.6% to close at $41.12 after the company reported Q3 earnings results.
Best Buy Co., Inc. (NYSE:BBY) fell 12.3% to close at $121.01 after the company reported third-quarter FY22 Enterprise sales growth of 0.5% year-on-year, to $11.91 billion, beating the analyst consensus of $11.56 billion. Enterprise comparable sales increased 1.6% versus 23.0% growth last year.
The Lovesac Company (NASDAQ:LOVE) fell 10.7% to close at $72.34. Andrew R Heyer, Insider at Lovesac, made a large insider sell on November 19, according to a new SEC filing.
Urban Outfitters, Inc. (NASDAQ:URBN) fell 9.3% to close at $33.80. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) fell 8.4% to close at $0.8068. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.
Relay Therapeutics, Inc. (NASDAQ:RLAY) fell 7.8% to close at $31.61.
Central Garden & Pet Company (NASDAQ:CENTA) dropped 6.3% to close at $46.59 following Q4 results.
Hibbett, Inc. (NASDAQ:HIBB) dropped 5.3% to close at $94.41. Hibbett is expected to issue its Q3 earnings release before the market opens on December 3, 2021.
DICK'S Sporting Goods, Inc. (NYSE:DKS) declined 4.1% to close at $134.55 following Q3 results.

Gainers

贏家

Aptevo Therapeutics Inc. (NASDAQ:APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
Pasithea Therapeutics Corp. (NASDAQ:KTTA) shares surged 153.4% to close at $5.60 on Tuesday after the company announced its subsidiary Pasithea Clinics has been approved to provide esketamine nasal spray for the treatment of resistant depression in adults.
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) surged 104.8% to close at $2.56 after a Zack's Small Cap research note showed a $9 price target on the stock.
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) jumped 81.6% to settle at $7.30. HC Wainwright & Co, on Monday, initiated coverage on Vallon Pharmaceuticals with a Buy rating and announced a price target of $12.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) gained 75.9% to settle at $2.34. The company filed proxy statement for annual meeting after the market close on Monday.
iSpecimen Inc. (NASDAQ:ISPC) gained 48.5% to close at $13.19. iSpecimen shares jumped over 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
MediciNova, Inc. (NASDAQ:MNOV) surged 44% to settle at $4.42. Zacks Small-Cap Research set $27 valuation on MediciNova.
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) gained 43% to close at $5.74 after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
Esperion Therapeutics, Inc. (NASDAQ:ESPR) surged 40.7% to settle at $10.02
Sunlands Technology Group (NYSE:STG) rose 23.2% to close at $4.51 after reporting unaudited Q3 results.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) rose 22.1% to close at $7.79. Gracell Biotech said members of its senior mgmt. team, including, Chair, CEO, CFO, Chief Medical Officer intend to use personal funds to buy up to $2 million in company’s ADSs in open market over next 3 months.
Dycom Industries, Inc. (NYSE:DY) climbed 19.7% to close at $99.91 following upbeat Q3 results.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) gained 15.1% to settle at $86.50 after the company reported Q4 earnings results.
BM Technologies, Inc. (NYSE:BMTX) jumped 14.9% to close at $13.82. Chardan Capital initiated coverage on BM Technologies with a Buy rating and announced a price target of $21.
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) rose 14.7% to close at $2.88. Unicycive Therapeutics recently posted a Q3 loss of $0.37 per share.
Reliance Global Group, Inc. (NASDAQ:RELI) gained 14.7% to settle at $2.42.
Armata Pharmaceuticals Inc. (NYSE:ARMP) jumped 14.3% to settle at $5.53. The FDA recently cleared Armata Pharmaceuticals’ Investigational New Drug (IND) for Phase 1b/2a study of AP-SA02 in Staphylococcus aureus bacteremia.
QIWI plc (NASDAQ:QIWI) rose 12.7% to settle at $8.70 after the company reported better-than-expected Q3 sales results.
Movado Group, Inc. (NYSE:MOV) gained 11.7% to close at $44.58 following Q3 results.
Dollar Tree, Inc. (NASDAQ:DLTR) surged 9.2% to settle at $144.71 after the company reported better-than-expected Q3 sales results.
Kosmos Energy Ltd. (NYSE:KOS) gained 9.1% to close at $3.71.
Burlington Stores, Inc. (NYSE:BURL) surged 8.6% to close at $285.55 after the company reported better-than-expected Q3 results.
XPeng Inc. (NYSE:XPEV) jumped 8.3% to close at $51.30. XPeng reported third-quarter revenues that exceeded expectations but the loss per share trailed expectations. The company's gross margins expanded both sequentially and year-over-year.
XL Fleet Corp. (NYSE:XL) gained 6.7% to close at $4.95 after the company announced it was awarded a pilot project with the Department of Defense to prototype fuel-saving technology for tactical vehicles.
Western Digital Corporation (NASDAQ:WDC) gained 6.3% to close at $60.53. Mizuho analyst Vijay Rakesh upgraded Western Digital to Buy from Neutral with a price target of $75, up from $55, implying a 31.7% upside.
Soligenix, Inc. (NASDAQ:SNGX) rose 5.8% to settle at $0.8790. Soligenix recently posted a Q3 loss of $0.09 per share.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares rose 4.9% to close at $0.4882. The FDA has signed off Tonix Pharmaceuticals’ Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.

Aptevo治療公司納斯達克(APVO：APVO)股價跳漲162.8%，收於17.03美元，此前該公司宣佈了評估APVO436治療急性髓系白血病的1b期擴大試驗的最新臨牀結果。
帕西婭治療公司(Pasithea Treateutics Corp.)納斯達克(Sequoia Capital：KTTA)股價週二飆升153.4%，收於5.6美元，此前該公司宣佈其子公司帕西西婭診所(Pasithea Clinics)已獲準提供埃斯氯胺酮鼻噴霧劑，用於治療成人難治性抑鬱症。
誇里根治療公司(Qualigen Treateutics，Inc.)納斯達克(Sequoia Capital：QLGN)暴漲104.8%，收於2.56美元，此前Zack‘s Small Cap研究報告顯示該股目標價為9美元。
瓦隆製藥公司納斯達克(Sequoia Capital：VLON)跳漲81.6%，收於7.3美元。週一，HC Wainwright&Co以買入評級啟動了對Vallon PharmPharmticals的覆蓋，並宣佈目標價為12美元。
Petros製藥公司納斯達克(Starbucks：PTPI)上漲75.9%，收於2.34美元。週一收盤後，該公司提交了年度會議的委託書。
ISpecimen Inc.納斯達克(Sequoia Capital：ISPC)上漲48.5%，收於13.19美元。週一，在宣佈簽約支持新冠肺炎的新的高級研究後，iSpecimen的股價躍升了超過80%，該研究旨在尋求對微博的傳播性、變種、結果和測試在多個人羣羣體中的有效性的見解。
MediciNova，Inc.納斯達克(Sequoia Capital：MNOV)暴漲44%，收於4.42美元。Zacks Small-Cap Research對MediciNova的估值為27美元。
克拉魯斯治療控股公司(Clarus Treateutics Holdings，Inc.)納斯達克(Kleiner Perkins Caufield&Byers)(CRXT：CRXT)股價上漲43%，收於5.74美元，此前該公司獲得一項名為“口服睾酮酯配方和治療睾酮缺乏症方法”的美國專利。
Esperion治療公司納斯達克(Sequoia Capital：ESPR)暴漲40.7%，結算價報10.02美元
尚德機構(紐約證券交易所代碼：STG)股價上漲23.2%，收於4.51美元，此前該公司公佈了未經審計的第三季度業績。
亙喜生物(Sequoia Capital Inc.)納斯達克(GRCL：GRCL)上漲22.1%，收於7.79美元。Gracell Biotech表示，其高級管理人員。包括董事長、首席執行官、首席財務官、首席醫療官在內的團隊打算在未來3個月內使用個人資金在公開市場購買最多200萬美元的公司美國存託憑證(ADS)。
戴姆康工業公司(Dycom Industries，Inc.)紐約證券交易所(NYSE：DY)股價上漲19.7%，收於99.91美元，第三季度業績樂觀。
Enanta製藥公司納斯達克(Kleiner Perkins Caufield&Byers)股價上漲15.1%，收於86.5美元，此前該公司公佈了第四季度收益業績。
BM技術公司(紐約證券交易所代碼：BMTX)跳漲14.9%，收於13.82美元。Chardan Capital以買入評級啟動了對BM Technologies的報道，並宣佈目標價為21美元。
Unicycive治療公司納斯達克(Sequoia Capital：UNCY)上漲14.7%，收報2.88美元。Unicycive Treeutics最近公佈第三季度每股虧損0.37美元。
信實全球集團有限公司(Reliance Global Group，Inc.)納斯達克(Sequoia Capital：REI)上漲14.7%，收於2.42美元。
阿瑪塔製藥公司(Armata PharmPharmticals Inc.)(紐約證券交易所代碼：ARMP)躍升14.3%，收於5.53美元。FDA最近批准了Armata製藥公司的研究新藥(IND)用於AP-SA02治療金黃色葡萄球菌菌血症的1b/2a階段研究。
QIWI plc納斯達克(Sequoia Capital：QIWI)股價上漲12.7%，收於8.70美元，此前該公司公佈了好於預期的第三季度銷售業績。
摩瓦多集團(Movado Group，Inc.)(紐約證券交易所代碼：MOV)在第三季度業績公佈後上漲11.7%，收於44.58美元。
美元樹公司納斯達克(Starbucks：DLTR)股價飆升9.2%，收於144.71美元，此前該公司公佈了好於預期的第三季度銷售業績。
科斯莫斯能源有限公司(紐約證券交易所代碼：KOS)上漲9.1%，收於3.71美元。
伯靈頓百貨公司(Burlington Stores，Inc.)(紐約證券交易所股票代碼：BURL)暴漲8.6%，收於285.55美元，此前該公司公佈了好於預期的第三季度業績。
小鵬汽車-W公司(紐約證券交易所代碼：XPEV)跳漲8.3%，收於51.30美元。小鵬汽車-W報告第三季度營收超出預期，但每股虧損低於預期。該公司的毛利率環比和同比均有所增長。
XL艦隊公司紐約證券交易所(NYSE：XL)股價上漲6.7%，收於4.95美元，此前該公司宣佈獲得國防部的一個試驗項目，用於戰術車輛的節油技術原型。
西部數據公司納斯達克(Starbucks：WDC)上漲6.3%，收於60.53美元。瑞穗(Mizuho)分析師維傑·拉凱什(Vijay Rakesh)將西部數據的評級從55美元上調至75美元，這意味着西部數據將上漲31.7%。
Soligix，Inc.納斯達克(SNGX：SNGX)上漲5.8%，收於0.8790美元。Soligix最近公佈第三季度每股虧損0.09美元。
東尼克斯製藥控股公司(Tonix PharmPharmticals Holding Corp.)納斯達克(Starbucks：TNXP)股價上漲4.9%，收於0.4882美元。FDA已經批准了Tonix製藥公司的研究新藥(IND)申請，啟動了治療偏頭痛的TNX-1900的第二階段研究。

Check out these big penny stock gainers and losers

看看這些微不足道的股票贏家和輸家

Losers

失敗者

Society Pass Incorporated (NASDAQ:SOPA) dipped 71.3% to close at $11.18 on Tuesday. The company, earlier during the month, priced its IPO at $9 per share.
Longeveron Inc. (NASDAQ:LGVN) shares dropped 38.9% to close at $17.22 on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
Enjoy Technology, Inc. (NASDAQ:ENJY) fell 33.5% to close at $4.30. Enjoy Technology recently posted Q3 loss of $0.83 per share.
Greenland Technologies Holding Corporation (NASDAQ:GTEC) fell 28.1% to close at $8.41. Greenland Technologies will present at the upcoming Sequire Cleantech & Electric Vehicle Investor Conference to be held virtually on December 6, 2021.
Genius Sports Limited (NYSE:GENI) fell 25.3% to close at $10.19 after the company reported better-than-expected Q3 sales results and raised FY21 sales guidance above estimates.
Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 22.2% to settle at $2.25.
Entrada Therapeutics, Inc. (NASDAQ:TRDA) dipped 20.6% to close at $24.13. Goldman Sachs initiated coverage on Entrada Therapeutics with a Neutral rating and announced a price target of $29.
Vinco Ventures, Inc. (NASDAQ:BBIG) declined 20% to close at $3.13. Vinco Ventures reported a third-quarter FY21 sales decline of 11.5% year-on-year, to $2.23 million.
Local Bounti Corp. (NYSE:LOCL) dipped 19.1% to settle at $8.01.
Aurora Innovation, Inc. (NASDAQ:AUR) fell 18.7% to close at $12.15.
Sarcos Technology and Robotics Corporation (NASDAQ:STRC) dropped 18% to settle at $6.58. Credit Suisse initiated coverage on Sarcos Technology with a Neutral rating and announced a price target of $9.
Benson Hill, Inc. (NYSE:BHIL) dipped 17.6% to settle at $6.10. Goldman Sachs initiated coverage on Benson Hill with a Neutral rating and announced a price target of $9.
Science 37 Holdings, Inc. (NASDAQ:SNCE) fell 17.1% to close at $9.43.
PainReform Ltd. (NASDAQ:PRFX) fell 17% to close at $1.91. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.
Femasys Inc. (NASDAQ:FEMY) dipped 16.8% to settle at $4.06.
Design Therapeutics, Inc. (NASDAQ:DSGN) fell 16.3% to close at $17.00.
Momentus Inc. (NASDAQ:MNTS) dropped 15.5% to settle at $6.88.
Tyra Biosciences, Inc. (NASDAQ:TYRA) declined 15.5% to settle at $19.34.
Zoom Video Communications, Inc. (NASDAQ:ZM) fell 14.7% to close at $206.64. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. B of A Securities downgraded Zoom from Buy to Neutral and lowered the price target from $385 to $270.
GameStop Corp. (NYSE:GME) dropped 13.6% to settle at $213.90 amid overall weakness as a rise in yields weighs on stocks.
Abercrombie & Fitch Co. (NYSE:ANF) fell 12.6% to close at $41.12 after the company reported Q3 earnings results.
Best Buy Co., Inc. (NYSE:BBY) fell 12.3% to close at $121.01 after the company reported third-quarter FY22 Enterprise sales growth of 0.5% year-on-year, to $11.91 billion, beating the analyst consensus of $11.56 billion. Enterprise comparable sales increased 1.6% versus 23.0% growth last year.
The Lovesac Company (NASDAQ:LOVE) fell 10.7% to close at $72.34. Andrew R Heyer, Insider at Lovesac, made a large insider sell on November 19, according to a new SEC filing.
Urban Outfitters, Inc. (NASDAQ:URBN) fell 9.3% to close at $33.80. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) fell 8.4% to close at $0.8068. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.
Relay Therapeutics, Inc. (NASDAQ:RLAY) fell 7.8% to close at $31.61.
Central Garden & Pet Company (NASDAQ:CENTA) dropped 6.3% to close at $46.59 following Q4 results.
Hibbett, Inc. (NASDAQ:HIBB) dropped 5.3% to close at $94.41. Hibbett is expected to issue its Q3 earnings release before the market opens on December 3, 2021.
DICK'S Sporting Goods, Inc. (NYSE:DKS) declined 4.1% to close at $134.55 following Q3 results.

協會通行證有限公司納斯達克(Sequoia Capital：SOPA)週二下跌71.3%，收於11.18美元。本月早些時候，該公司將IPO定價為每股9美元。
隆格韋隆公司(Longeveron Inc.)納斯達克股價週二下跌38.9%，收於17.22美元。該公司上週宣佈，FDA授予Lomecel-B治療左心發育不良綜合徵的罕見兒科疾病稱號。
樂享科技有限公司納斯達克(Sequoia Capital：ENJY)跌33.5%，收於4.3美元。愉悦科技最近公佈第三季度每股虧損0.83美元。
格陵蘭技術控股公司納斯達克(GTEC：GTEC)跌28.1%，收報8.41美元。格陵蘭技術公司將出席即將於2021年12月6日舉行的Sequire Cleantech&電動汽車投資者大會(Sequire Cleantech&Electric Vehicle Investor Conference)。
天才體育有限公司(紐約證券交易所代碼：GENI)股價下跌25.3%，收於10.19美元，此前該公司公佈了好於預期的第三季度銷售業績，並上調了21財年的銷售指引，高於預期。
格羅姆社會企業公司納斯達克(Starbucks：Grom)下跌22.2%，收於2.25美元。
Entrada治療公司納斯達克(Sequoia Capital：TRDA)下跌20.6%，收於24.13美元。高盛(Goldman Sachs)以中性評級啟動了對Entrada治療公司的報道，並宣佈目標價為29美元。
Vinco Ventures，Inc.納斯達克(Sequoia Capital：BBIG)下跌20%，收於3.13美元。Vinco Ventures報告21財年第三季度銷售額同比下降11.5%，至223萬美元。
當地邦蒂公司(Local Bounti Corp.)(紐約證券交易所代碼：Locl)下跌19.1%，收於8.01美元。
奧羅拉創新公司納斯達克(Starbucks：AUR)下跌18.7%，收於12.15美元。
薩科斯技術和機器人公司納斯達克(Sequoia Capital：STRC)下跌18%，收於6.58美元。瑞士信貸(Credit Suisse)以中性評級啟動了對Sarcos Technology的覆蓋，並宣佈目標價為9美元。
本森·希爾公司(Benson Hill，Inc.)(紐約證券交易所代碼：BHIL)下跌17.6%，收於6.10美元。高盛(Goldman Sachs)以中性評級啟動了對本森山(Benson Hill)的報道，並宣佈目標價為9美元。
科學37控股公司納斯達克(Starbucks：SNCE)下跌17.1%，收於9.43美元。
畫改有限公司納斯達克(Starbucks：PRFX)下跌17%，收於1.91美元。PainReform最近公佈，在截至9月1日的9個月中，淨虧損550萬美元。30,2021年。
Femasys Inc.納斯達克(Weibo：FAMY)下跌16.8%，收於4.06美元。
設計治療公司納斯達克(DSGN：DSGN)下跌16.3%，收於17.00美元。
Momentus Inc.納斯達克(Sequoia Capital：MNTS)下跌15.5%，收於6.88美元。
泰拉生物科學公司納斯達克(TYRA：TYRA)下跌15.5%，收於19.34美元。
Zoom Video Communications，Inc.納斯達克(Sequoia Capital：ZM)下跌14.7%，收於206.64美元。Zoom Video週一公佈第三季業績優於預期。該公司報告稱，在過去12個月中貢獻超過10萬美元的客户總數為2,507人，同比增長94%。B of A Securities將Zoom評級從買入下調至中性，目標價從385美元下調至270美元。
GameStop公司(紐約證券交易所股票代碼：GME)下跌13.6%，收於213.90美元，整體疲軟，收益率上升令股市承壓。
Abercrombie&Fitch Co.(紐約證券交易所股票代碼：ANF)下跌12.6%，收於41.12美元，此前該公司公佈了第三季度收益業績。
百思買(Best Buy Co.，Inc.)BBY(紐約證券交易所股票代碼：BBY)下跌12.3%，收於121.01美元，此前該公司公佈22財年第三季度企業銷售額同比增長0.5%，至19.1億美元，超出分析師一致預期的15.6億美元。企業可比銷售額增長了1.6%，而去年的增幅為23.0%。
洛維薩克公司納斯達克(Weibo：LOVE)跌10.7%，收報72.34美元。一份新的美國證券交易委員會備案文件顯示，洛維薩克的內部人士安德魯·R·海耶(Andrew R Heyer)在11月19日進行了一次大規模的內幕出售。
城市用品公司(Urban Outfitters，Inc.)納斯達克(Sequoia Capital：URBN)下跌9.3%，收於33.8美元。Urban Outfitters公佈了第三季度樂觀的收益和銷售業績。該季度其同店銷售額同比增長14.6%。
亞達米斯製藥公司納斯達克(Sequoia Capital：ADMP)下跌8.4%，收於0.8068美元。Adamis製藥公司表示，截至9月1日的9個月的銷售額。302021年的收入為340萬美元。
接力治療公司(Relay Treeutics，Inc.)納斯達克(Sequoia Capital：RLAY)下跌7.8%，收於31.61美元。
中央花園寵物公司納斯達克(Kleiner Perkins Caufield&Byers)第四季度財報公佈後，股價下跌6.3%，收於46.59美元。
Hibbett，Inc.納斯達克(Standard Chartered Bank：HIBB)下跌5.3%，收於94.41美元。Hibbett預計將在2021年12月3日市場開盤前發佈第三季度收益報告。
迪克體育用品公司(紐約證券交易所股票代碼：DKS)在第三季度業績公佈後下跌4.1%，收於134.55美元。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

56 Biggest Movers From Yesterday

56 Biggest Movers From Yesterday

Gainers

Losers

Gainers

贏家

Losers

失敗者

風險及免責聲明

聲明